Burning Rock Biotech (BNR) Income from Continuing Operations (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly Income from Continuing Operations of 2464000.0 for Q1 2026, down 36.89% year-over-year from 3904225.35 in Q1 2025, and down 26.42% quarter-over-quarter from 1949000.0 in Q4 2025.
Burning Rock Biotech (BNR) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Burning Rock Biotech's Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 2464000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 36.89% year-over-year to 2464000.0; the TTM figure through Mar 2026 stood at 7994000.0 (up 74.49% YoY), while the FY2025 annual figure was 7803376.48, up 83.57% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 2464000.0, down from 1949000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1286000.0 in Q2 2025, with the low at 41233000.0 in Q1 2022.
- The 5-year median for Income from Continuing Operations is 16785000.0 (2024), against an average of 17119880.78.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 57.61% in 2022, then soared 91.32% in 2025.
- Burning Rock Biotech's Income from Continuing Operations stood at 30806711.65 in 2022, then rose by 26.81% to 22546000.0 in 2023, then soared by 57.06% to 9681000.0 in 2024, then surged by 79.87% to 1949000.0 in 2025, then retreated by 26.42% to 2464000.0 in 2026.
- Business Quant data shows BNR's Income from Continuing Operations at 2464000.0 in Q1 2026, 1949000.0 in Q4 2025, and 2295000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Burning Rock Biotech | 781.17 Mn | 711.04 Mn | 11.31 Mn | -2.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.46 Mn |
| Dec 31, 2025 | -1.95 Mn |
| Sep 30, 2025 | -2.30 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.80 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Sep 30, 2024 | -5.04 Mn |
| Jun 30, 2024 | -14.81 Mn |
| Mar 31, 2024 | -16.79 Mn |
| Dec 31, 2023 | -22.55 Mn |
| Sep 30, 2023 | -23.86 Mn |
| Jun 30, 2023 | -17.98 Mn |
| Mar 31, 2023 | -26.85 Mn |
| Dec 31, 2022 | -30.81 Mn |
| Sep 30, 2022 | -32.54 Mn |
| Jun 30, 2022 | -39.11 Mn |
| Mar 31, 2022 | -41.23 Mn |
| Dec 31, 2021 | -39.77 Mn |
| Sep 30, 2021 | -26.33 Mn |
| Jun 30, 2021 | -31.04 Mn |